Biomea Fusion is a biopharmaceutical company focused on discovering and developing oral covalent small molecules to treat metabolic diseases and genetically defined cancers. Their proprietary FUSION™ System enables the development of highly selective and durable treatments, with lead candidates targeting menin, FLT3, and GLP-1 receptors.
Biomea Fusion Highlights:
Overview
- Website: biomeafusion.com
- Headquarters: Redwood City, California
- Employees: 126
- Founded: 2017
- Email: info@biomeafusion.com
- Funding: $56.0M
- Revenue: $7.8M
- Valuation: n/a
Contacts
- Email: ***@biomeafusion.com
Similar companies
Frequently Asked Questions related to Biomea Fusion
Biomea Fusion is located in Redwood City, California.
Yes, Biomea Fusion is a Silicon Valley company.
Biomea Fusion total funding is 56.0M.
Biomea Fusion revenue is 7.8M.
Biomea Fusion’s number of employees is 126.
Biomea Fusion’s CEO name is Franco V.
Biomea Fusion was founded in 2017.
Biomea Fusion’s contact email is info@biomeafusion.com.
